King's College London, Thames Cancer Registry, 1st Floor, Capital House, 42 Weston Street, London SE1 3QD, UK.
Br J Cancer. 2012 Sep 25;107(7):1195-202. doi: 10.1038/bjc.2012.366. Epub 2012 Aug 14.
There are currently two million cancer survivors in the United Kingdom, and in recent years this number has grown by 3% per annum. The aim of this paper is to provide long-term projections of cancer prevalence in the United Kingdom.
National cancer registry data for England were used to estimate cancer prevalence in the United Kingdom in 2009. Using a model of prevalence as a function of incidence, survival and population demographics, projections were made to 2040. Different scenarios of future incidence and survival, and their effects on cancer prevalence, were also considered. Colorectal, lung, prostate, female breast and all cancers combined (excluding non-melanoma skin cancer) were analysed separately.
Assuming that existing trends in incidence and survival continue, the number of cancer survivors in the United Kingdom is projected to increase by approximately one million per decade from 2010 to 2040. Particularly large increases are anticipated in the oldest age groups, and in the number of long-term survivors. By 2040, almost a quarter of people aged at least 65 will be cancer survivors.
Increasing cancer survival and the growing/ageing population of the United Kingdom mean that the population of survivors is likely to grow substantially in the coming decades, as are the related demands upon the health service. Plans must, therefore, be laid to ensure that the varied needs of cancer survivors can be met in the future.
目前英国有 200 万癌症幸存者,近年来这一数字以每年 3%的速度增长。本文旨在对英国癌症的流行情况进行长期预测。
利用英格兰国家癌症登记处的数据,估计 2009 年英国的癌症流行情况。利用发病率、生存率和人口统计学为函数的流行模型,对 2040 年进行了预测。还考虑了不同的未来发病率和生存率情景及其对癌症流行率的影响。分别对结直肠癌、肺癌、前列腺癌、女性乳腺癌和所有癌症(不包括非黑素瘤皮肤癌)进行了分析。
假设发病率和生存率的现有趋势继续下去,那么从 2010 年到 2040 年,英国癌症幸存者的人数每十年将增加约 100 万。在最年长的年龄组和长期幸存者的数量上,预计会有特别大的增长。到 2040 年,至少 65 岁的人群中几乎有四分之一将是癌症幸存者。
由于癌症生存率的提高和英国人口的增长/老龄化,未来几十年,幸存者的人数很可能会大幅增加,对卫生服务的需求也会相应增加。因此,必须制定计划,以确保未来能够满足癌症幸存者的各种需求。